Skip to main content

Published locations for Durvalumab combos beat monotherapy for unresectable stage 3 NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Durvalumab combos beat monotherapy for unresectable stage 3 NSCLC

User login

  • Reset your password
  • /content/durvalumab-combos-beat-monotherapy-unresectable-stage-3-nsclc
  • /internalmedicinenews/article/246336/lung-cancer/durvalumab-combos-beat-monotherapy-unresectable
  • /oncologypractice/article/246336/lung-cancer/durvalumab-combos-beat-monotherapy-unresectable-stage-3
  • /node/155702/article/246336/lung-cancer/durvalumab-combos-beat-monotherapy-unresectable-stage-3-nsclc
  • /hematology-oncology/article/246336/lung-cancer/durvalumab-combos-beat-monotherapy-unresectable-stage
  • /internalmedicine/article/246336/lung-cancer/durvalumab-combos-beat-monotherapy-unresectable-stage-3